Cargando…
Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation
Although corticotropin-releasing hormone (CRH) and Fas ligand (FasL) have been documented in ovarian carcinoma, a clear association with tumour progression and immuno-escape has not been established. FasL plays an important role in promoting tumour cells' ability to counterattack immune cells....
Autores principales: | Minas, V, Rolaki, A, Kalantaridou, S N, Sidiropoulos, J, Mitrou, S, Petsas, G, Jeschke, U, Paraskevaidis, E A, Fountzilas, G, Chrousos, G P, Pavlidis, N, Makrigiannakis, A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360374/ https://www.ncbi.nlm.nih.gov/pubmed/17667919 http://dx.doi.org/10.1038/sj.bjc.6603918 |
Ejemplares similares
-
The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability
por: Henkler, Frank, et al.
Publicado: (2005) -
Decidual Macrophages Are Significantly Increased in Spontaneous Miscarriages and Over-Express FasL: A Potential Role for Macrophages in Trophoblast Apoptosis
por: Guenther, Sabine, et al.
Publicado: (2012) -
The Fas/FasL System in Reproduction: Survival and Apoptosis
por: Mor, Gil, et al.
Publicado: (2002) -
Role of the Fas/FasL pathway in HIV or SIV disease
por: Poonia, Bhawna, et al.
Publicado: (2009) -
Involvement of Fas/FasL pathway in the murine model of atopic dermatitis
por: Bień, Karolina, et al.
Publicado: (2017)